Luigi Naldini

from Wikipedia, the free encyclopedia

Luigi Naldini (* 1959 in Turin ) is an Italian gene therapist at the Università Vita-Salute San Raffaele in Milan .

Naldini holds an MD from the University of Turin and a Ph.D. from the University of Rome. In the mid-1990s, Naldini went to Inder M. Verma and Didier Trono at the Salk Institute for Biological Studies . After two years in a biotechnology company in San Francisco , he moved back to Turin. Since 2008 he has been the director of the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) in Milan . He also holds a professorship for cell and tissue biology at the Università Vita-Salute San Raffaele .

Verma, Trono and Naldini jointly developed HIV- safe vectors for gene transfer from the lentivirus . Almost one hundred patients with otherwise fatal hereditary diseases (such as adrenoleukodystrophy , metachromatic leukodystrophy , Wiskott-Aldrich syndrome and other congenital immunodeficiency syndromes ) have been successfully treated with gene therapy. Most recently, the procedure was expanded to include β-thalassemia . More recent work by Naldini deals with genome editing .

According to Google Scholar (as of February 2009), Naldini has an h-index of 105.

In 2008 Naldini was elected to the European Molecular Biology Organization (EMBO). In 2014 he was awarded the Gili Agostinelli of the Accademia delle Scienze di Torino , and in 2019 the Louis-Jeantet Prize for Medicine (here as the Jeantet-Collen Prize for Translational Medicine ). He was President of the European Society of Gene and Cell Therapy (ESGCT) and received an honorary doctorate from the Vrije Universiteit Brussel in 2015 .

Web links

Individual evidence

  1. Luigi Naldini. In: scholar.google.de. Google Scholar , accessed February 24, 2019 .
  2. Luigi Naldini. In: embo.org. European Molecular Biology Organization, accessed February 24, 2019 .
  3. Gili Agostinelli 2014. In: accademiadellescienze.it. Accademia delle Scienze, accessed February 24, 2019 (Italian).
  4. ^ Luigi Naldini - Winner of the 2019 Jeantet-Collen Prize for Translational Medicine. In: jeantet.ch. Fondation Louis-Jeantet , accessed on February 24, 2019 .